Calling nutraceuticals fundamentally different from pharmaceutical drugs, IDMA said preserving their OTC status is critical to improving consumer access, supporting preventive healthcare and advancing India’s Viksit Bharat 2047 vision.
News
Nutraceuticals must remain OTC products to drive preventive healthcare: IDMA
July 6, 2026Calling nutraceuticals fundamentally different from pharmaceutical drugs, IDMA said preserving their OTC status is critical to improving consumer access, supporting preventive healthcare and advancing India’s Viksit Bharat 2047 vision.